Navamedic ASA (OSL:NAVA)

Navamedic ASA Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 3, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	537	454	637	601	556	292
Market Cap Growth	24.14%	-28.72%	5.92%	8.19%	90.28%	33.03%
Enterprise Value	797	534	720	625	561	288
Last Close Price	22.40	25.27	36.09	34.32	33.43	18.78
PE Ratio	-	-	-	20.43	899.28	-
PS Ratio	1.00	0.85	1.24	1.57	2.00	1.39
PB Ratio	2.56	2.10	3.10	2.87	3.68	2.26
P/TBV Ratio	-	-	-	7.67	8.84	5.28
P/FCF Ratio	-	12.60	-	38.32	-	-
P/OCF Ratio	36.66	11.54	292.27	33.51	-	-
EV/Sales Ratio	1.48	1.01	1.41	1.64	2.02	1.37
EV/EBITDA Ratio	24.66	12.30	14.65	12.60	34.77	-
EV/EBIT Ratio	74.35	16.81	18.17	14.07	49.01	-
EV/FCF Ratio	-4.56	14.83	-	39.84	-	-
Debt / Equity Ratio	1.49	0.55	0.74	0.28	0.31	0.18
Debt / EBITDA Ratio	9.64	2.55	2.96	1.14	2.57	-
Debt / FCF Ratio	-	3.29	-	3.74	-	-
Asset Turnover	0.87	1.09	1.15	1.07	0.94	0.94
Inventory Turnover	3.30	3.48	3.39	3.09	3.21	3.78
Quick Ratio	0.72	0.66	0.49	0.90	0.78	0.72
Current Ratio	1.49	1.42	1.11	1.93	1.51	1.12
Return on Equity (ROE)	-15.99%	-2.60%	-6.59%	16.31%	0.44%	-15.77%
Return on Assets (ROA)	1.08%	4.08%	5.57%	7.79%	2.43%	-1.38%
Return on Invested Capital (ROIC)	2.84%	10.29%	14.86%	17.17%	2.33%	-4.78%
Return on Capital Employed (ROCE)	1.90%	9.70%	12.50%	17.30%	5.90%	-3.20%
Earnings Yield	-7.05%	-1.21%	-2.15%	4.90%	0.11%	-5.64%
FCF Yield	-32.52%	7.94%	-0.00%	2.61%	-0.36%	-1.15%
Buyback Yield / Dilution	-	-1.24%	-1.48%	-3.60%	-13.61%	-23.54%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.